Supernus Pharmaceuticals, Inc. (SUPN) NASDAQ

44.07

-0.69(-1.54%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap2.81B
Enterprise Value2.72B
P/E Ratio-87.56
PEG Ratio0.9
Price/Sales Ratio3.29
Price/Book Ratio2.36
Enterprise/Revenue3.11
Enterprise/EBITDA55.56

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.04
Operating Margin-0.05

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue718.95M
Revenue/Share13.48
Gross Profit644.39M
EBITDA42.53M
Net Income-38.55M
Diluted EPS-0.68

Balance Sheet

Total Cash384.24M
Total Cash/Share6.67
Total Debt40.9M
Total Debt/Equity0.04
Current Ratio1.96
Book Value Per Share18.68

Price History

52-Week Change38.11
52-Week High59.68
52-Week Low30.83
Moving Average 50 Days49.57
Moving Average 200 Days48.95

Statistics

Average Volume642,334
Shares Outstanding58.04M
% Held by Institutions103.13

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A